Holen Sie sich die Stockscreener-App
27.47
0.62%
-0.17
Handel nachbörslich:
27.50
0.03
+0.11%
Moderna Inc Aktie (MRNA) Neueste Nachrichten
Barclays Has Lowered Expectations for Moderna (NASDAQ:MRNA) Stock Price - MarketBeat
Moderna: RSV Upside Slim, Cash Burn Heavy (NASDAQ:MRNA) - Seeking Alpha
Let’s make a deal? Big Pharma execs express varying views on their M&A future - PharmaVoice
Lipid Nanoparticles Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034 - GlobeNewswire Inc.
Zurcher Kantonalbank Zurich Cantonalbank Sells 134,443 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Wealthquest Corp Takes $1.04 Million Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 - The Florida Times-Union
UK Court of Appeal Confirms Moderna’s EP’949 Patent is Valid and Infringed by Pfizer/BioNTech - Pocono Record
Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates - The Courier-Journal
Moderna Seeks To Be Cleared In $5B COVID Vax Patent Case - Law360
BofA Securities lowers Moderna stock price target to $24 on COVID reliance - Investing.com
EU regulator backs Moderna's updated COVID vaccine - MSN
Moderna Tops Vaccine Expectations But Trims Future Outlook - Finimize
Moderna stock falls as UBS reiterates Buy rating amid cost cuts - Investing.com Canada
How the U.S. mRNA Therapeutics Market Will Evolve by 2032 - openPR.com
Moderna Q2 Earnings Review: Downsizing Triggers Selloff, But I'm Long-Term Bullish (MRNA) - Seeking Alpha
Moderna (NASDAQ:MRNA) Announces Quarterly Earnings Results - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Has $1.16 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
XTX Topco Ltd Raises Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Banque Cantonale Vaudoise Takes Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
What is Moderna Inc. company’s growth strategyPowerful profit generation - Jammu Links News
Private Advisor Group LLC Sells 13,174 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
What analysts say about Moderna Inc. stockMaximize your portfolio’s growth potential - jammulinksnews.com
Moderna: Is Now the Time to Buy the Deep Value Dip? - FXEmpire
Moderna’s Hold Rating: Navigating Revenue Adjustments and Product Development Uncertainties - TipRanks
What are Moderna Inc. company’s key revenue driversHigh-octane gains - jammulinksnews.com
Novo Nordisk, United Parcel Service, And Moderna Are Among Top 10 Large Cap Losers Last Week (July 28-August 1): Are The Others In Your Portfolio? - Benzinga
When is Moderna Inc. stock expected to show significant growthHigh-octane financial growth - Jammu Links News
Is Moderna Inc. a growth stock or a value stockBuild wealth faster with expert stock selection - Jammu Links News
What institutional investors are buying Moderna Inc. stockUnrivaled growth potential - Jammu Links News
Letko Brosseau & Associates Inc. Has $25.41 Million Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna Sees Unusually High Options Volume (NASDAQ:MRNA) - MarketBeat
Moderna (NASDAQ:MRNA) Shares Gap DownTime to Sell? - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Q2 2025 Earnings Call Transcript - Insider Monkey
Pacer Advisors Inc. Cuts Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna Inc (MRNA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Cost ... - Yahoo Finance
Moderna Inc (MRNA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Cost Reductions and New Approvals - GuruFocus
Moderna’s Q2 2025 Financial Results and Outlook - TipRanks
Moderna Outpaces Losses With Cost Cuts And New Plans - Finimize
Moderna's Q2 Earnings and Strategic Cost Cuts: A Path to Sustainable Recovery? - AInvest
Moderna: Q2 Earnings Snapshot - Norwalk Hour
Here's What Key Metrics Tell Us About Moderna (MRNA) Q2 Earnings - Yahoo Finance
Moderna Cuts Outlook And Jobs As Vaccine Sales Wane - Finimize
Moderna, Inc. SEC 10-Q Report - TradingView
Moderna Cuts Forecast, Stock Wobbles Despite Beat - Yahoo Finance
Moderna plans to slash 10% of workforce - The American Bazaar
Moderna Sales Top Estimates As Cost Cuts Bite - Finimize
Moderna sharpens focus on $1.5bn cost cutting plan after 41% revenue slump - Yahoo Finance
MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View - TradingView
Moderna cuts sales forecast on UK revenue delay, shares fall - Reuters
Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win - Reuters
Why Moderna (MRNA) Stock Is Trading Lower Today - Yahoo Finance
Earnings live: Exxon, Chevron oil output boosts profits, Moderna stock tumbles, Amazon sinks - Yahoo Finance
Moderna would provide Merck an M&A booster - TradingView
Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent - Fast Company
Moderna Fights Off Pfizer Challenge To Surviving mRNA IP - Law360
0.40%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):